178 related articles for article (PubMed ID: 17475966)
41. Abdominal positron-emission tomography lesions with increased standardized uptake values correlate with intraoperative findings.
Horst S; Kocak E; Young D; Mantil J; Martin EW
Am J Surg; 2006 Jan; 191(1):39-44. PubMed ID: 16399104
[TBL] [Abstract][Full Text] [Related]
42. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
[TBL] [Abstract][Full Text] [Related]
43. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil.
Moehler M; Dimitrakopoulou-Strauss A; Gutzler F; Raeth U; Strauss LG; Stremmel W
Cancer; 1998 Jul; 83(2):245-53. PubMed ID: 9669806
[TBL] [Abstract][Full Text] [Related]
44. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer.
Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M
Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242
[TBL] [Abstract][Full Text] [Related]
45. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
46. Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Xu HL; Li M; Zhang RJ; Jiang HJ; Zhang MY; Li X; Wang YQ; Pan WB
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):140-148. PubMed ID: 29571649
[TBL] [Abstract][Full Text] [Related]
47. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
[TBL] [Abstract][Full Text] [Related]
48. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL
Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212
[TBL] [Abstract][Full Text] [Related]
49. FDG-PET improves management of patients with colorectal liver metastases allocated for local treatment: a consecutive prospective study.
Sørensen M; Mortensen FV; Høyer M; Vilstrup H; Keiding S;
Scand J Surg; 2007; 96(3):209-13. PubMed ID: 17966746
[TBL] [Abstract][Full Text] [Related]
50. 18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.
Choi JY; Jang HJ; Shim YM; Kim K; Lee KS; Lee KH; Choi Y; Choe YS; Kim BT
J Nucl Med; 2004 Nov; 45(11):1843-50. PubMed ID: 15534053
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.
Takahashi S; Kuroki Y; Nasu K; Nawano S; Konishi M; Nakagohri T; Gotohda N; Saito N; Kinoshita T
Anticancer Res; 2006; 26(6C):4705-11. PubMed ID: 17214330
[TBL] [Abstract][Full Text] [Related]
52. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil.
Findlay M; Young H; Cunningham D; Iveson A; Cronin B; Hickish T; Pratt B; Husband J; Flower M; Ott R
J Clin Oncol; 1996 Mar; 14(3):700-8. PubMed ID: 8622014
[TBL] [Abstract][Full Text] [Related]
53. [Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma].
Kong YH; Han CJ; Lee SD; Sohn WS; Kim MJ; Ki SS; Kim J; Jeong SH; Kim YC; Lee JO; Cheon GJ; Choi CW; Lim SM
Korean J Hepatol; 2004 Dec; 10(4):279-87. PubMed ID: 15613803
[TBL] [Abstract][Full Text] [Related]
54. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG.
Buck AK; Halter G; Schirrmeister H; Kotzerke J; Wurziger I; Glatting G; Mattfeldt T; Neumaier B; Reske SN; Hetzel M
J Nucl Med; 2003 Sep; 44(9):1426-31. PubMed ID: 12960187
[TBL] [Abstract][Full Text] [Related]
55. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
[TBL] [Abstract][Full Text] [Related]
56. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Higashi K; Ueda Y; Arisaka Y; Sakuma T; Nambu Y; Oguchi M; Seki H; Taki S; Tonami H; Yamamoto I
J Nucl Med; 2002 Jan; 43(1):39-45. PubMed ID: 11801701
[TBL] [Abstract][Full Text] [Related]
57. Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.
Brenner W; Friedrich RE; Gawad KA; Hagel C; von Deimling A; de Wit M; Buchert R; Clausen M; Mautner VF
Eur J Nucl Med Mol Imaging; 2006 Apr; 33(4):428-32. PubMed ID: 16404595
[TBL] [Abstract][Full Text] [Related]
58. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
59. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
[TBL] [Abstract][Full Text] [Related]
60. 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer.
Pauleit D; Zimmermann A; Stoffels G; Bauer D; Risse J; Flüss MO; Hamacher K; Coenen HH; Langen KJ
J Nucl Med; 2006 Feb; 47(2):256-61. PubMed ID: 16455631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
